comparemela.com

Latest Breaking News On - Asco recommendations - Page 1 : comparemela.com

Testing for ESR1 Mutations in Breast Cancer

Kevin Kalinsky, MD, MS, and Erica L. Mayer, MD, MPH, discuss testing practices for ESR1 mutations in patients with breast cancer.

Erical-mayer
Kevin-kalinsky
Breast-cancer
Hr-breast-cancer
Hr-positive-breast-cancer
Breast-cancer-treatment
Esr1
Esr1-mutations
Biomarker-testing
Esr1-testing
Asco-recommendations

Overcoming Challenges in Biomarker Testing in Breast Cancer

Experts on breast cancer discuss challenges encountered in biomarker testing for patients with breast cancer.

Breast-cancer
Biomarker-testing
Hr-breast-cancer
Hr-positive-breast-cancer
Breast-cancer-treatment
Esr1
Esr1-mutations
Esr1-testing
Asco-recommendations
Ctdna
Circulating-tumor-dna

ASCO Recommends Trilaciclib in Extensive-Stage Small Cell Lung Cancer in Guideline Update

In their updated guidelines for patients with small cell lung cancer (SCLC), ASCO has recommended the CDK4/6 inhibitor trilaciclib as a myeloid supportive agent for patients with untreated or previously treated extensive-stage SCLC who are receiving chemotherapy or chemoimmunotherapy.

United-states
American
Raj-malik
Health-cancer-care-ontario-guideline
American-society-of-clinical-oncology
American-society
Clinical-oncology
Ontario-health
Cancer-care-ontario
Small-cell-lung-cancer
Nsclc
Pasco

vimarsana © 2020. All Rights Reserved.